How people with Parkinson's disease perceive social cues
Official title: Social Perception and Dopaminergic Modulation in Patients With Parkinson's Disease: a Functional MRI Study (Park Social-E-Motion)
Run by Hospices Civils de Lyon · NCT06884722 · Data updated 2026-11-12
This trial tries to see if dopaminergic medication changes brain activity during social perception tasks in people with Parkinson's disease using a behavioral point-light display task and 3T fMRI.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 30 Years to 75 Years |
| Sex | All |
| Enrollment | 83 (estimated) |
| Sponsor | Hospices Civils de Lyon Academic / other |
| Locations | 1 site (Bron) |
| Status | Recruiting |
| Started | July 15, 2025 |
| Main results expected | April 2027 |
| Study ends | April 2027 |
| Registry record updated | July 22, 2025 |
| Trial ID | NCT06884722 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates are men or women age 30–75 with a Parkinson's diagnosis for at least three years who are on dopaminergic treatment, have MoCA ≥ 26, can give informed consent, and can attend imaging visits including standard dopa testing.
✕Probably not a fit
People with disabling chronic diseases, significant cognitive impairment (MoCA < 26), contraindications to MRI, or who are not receiving dopaminergic therapy are unlikely to benefit from this protocol.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This interventional study enrolls people with Parkinson's disease who have been on dopaminergic treatment for at least three years and who have preserved global cognition. Participants complete a behavioral task using point-light displays of social interactions and undergo 3 Tesla functional MRI to map networks involved in movement perception, action observation, and mentalizing. The protocol includes neurological and neuropsychological assessments and examines the effect of dopaminergic modulation on those networks (for the imaging stage). Data will be used to relate task performance to activity in motor, parietal, and superior temporal sulcus regions implicated in social cognition.
Why it matters
Potential benefit: If successful, this could clarify why social perception is impaired in Parkinson's and guide medication or behavioural approaches to improve social functioning and relationships.
How similar studies have gone: Previous research has demonstrated altered social cognition and related brain activation in Parkinson's disease, but using point-light displays with dopaminergic modulation and 3T fMRI is a relatively novel combination.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Male or female between 30 and 75 years of age * Freely-given informed consent to participate to this study (written form) * Affiliated with a social security system or equivalent; * Person diagnosed with Parkinson's disease according to MDS-UPDRS criteria for at least 3 years and receiving dopaminergic treatment (e.g. : LEVODOPA, CARBIDOPA, BENZERASIDE, ENTACAPONE, MODOPAR, SINEMET, STALEVO, PRAMIPEXOLE, SIFROL, ROPINIROLE, REQUIP ; ROTIGOTINE, NEUPRO, PIRIBEDIL, TRIVASTAL, RASAGILINE, AZILECT, CONTAM, AMANTADINE, MANTADIX, APOMORPHINE, APOKINON, DOPACEPTIN, FOSLEVODOPA, FOSCARBIDOPA, SCYOVA) (for patients only) * Effective contraception for women of childbearing age or post-menopausal women (only for patients and healthy volunteers in stage 2 "imaging") * Requiring dopa testing as part of routine care (only for patients in stage 2 "imaging") * No disabling cognitive impairment (MOCA score ≥ 26) * No diagnosis of chronic disease associated with disability (only for healthy volunteers) Exclusion Criteria: * Contraindication to MRI (only for patients and healthy volunteers in step 2 "imaging"): * Wearing a pacemaker not approved for 3 Tesla MRI * Presence of intracerebral ferromagnetic or magnetizable material * Presence of intraocular ferromagnetic or magnetizable foreign bodies * Presence of non-removable ferro-magnetic or magnetizable foreign bodies in the cephalic region * Claustrophobia * History of head trauma with loss of consciousness lasting more than 30 min (only for patients and healthy volunteers in step 2 "imaging") * Participant not agreeing to be informed in the event of incidental discovery of an abnormality on MRI (only for patients and healthy volunteers in stage 2 "imaging") * Tremor or disabling dyskinesias preventing MRI (only for patients in stage 2) * Having exceeded the annual amount of compensation allowed for participation in research protocols (only for healthy volunteers) * Pregnant, parturient or breast-feeding women * Persons deprived of liberty by judicial or administrative decision * Persons under psychiatric care * Persons admitted to a health or social institution for purposes other than research * Adults under legal protection (guardianship, curatorship) * Participants in other intervention research involving a period of exclusion still in progress at the time of pre-inclusion.
Where it's running
-
Service de neurologie - troubles du mouvement et pathologies neuromusculaires, Hôpital neurologique Pierre Wertheimer/GHE
Bron, France Recruiting
Study contacts
- Study coordinator: Stéphane PRANGE, MD, PhD
- Email: stephane.prange@chu-lyon.fr
- Phone: 472 357 222
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Blood viscosity in ARDS: a look at how thick the blood is
This study tests whether blood viscosity is higher in adults with ARDS and whether viscosity relates to their breathing and blood flow issues.
-
Virus interactions in hospitalized patients during winter seasons in Lyon
This study tests all virological results from hospitalized patients in Lyon during winter to see how different respiratory viruses may co-occur or exclude each other.
-
Surgical Use of Efanoctocog alfa in Hemophilia A Patients
This observational study looks at how efanesoctocog alfa (Altuvoct) is used around surgery in people with hemophilia A to see if it helps control bleeding.
-
Sleep quality and its determinants during the liver transplant pathway
This study tests how sleep quality changes from before liver transplantation to six months after, in adults on the transplant waitlist at a single hospital.
-
Compare Trans-Stomal Bladder Lithotripsy Methods in Continent Catheterizable Urinary Reservoirs
This study looks at different ways to break up bladder stones in people with continent catheterizable urinary diversions to see which method works best when the normal route isn’t available.
-
French version validation of the New Mobility Score for older adults after hip fracture
This study tests whether the French version of the New Mobility Score accurately measures mobility in French patients aged 75 and older after hip fracture.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.